Aeterna Zentaris

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch AEZS and buy or sell other stocks, ETFs, and their options commission-free!

About AEZS

COSCIENS Biopharma Inc. engages in the development and commercialization of diverse pharmaceutical and diagnostic products. It operates through the Active Ingredient and Biopharmaceutical segments. 

CEO
Anna Elizabeth Biehn, MBA
CEOAnna Elizabeth Biehn, MBA
Employees
40
Employees40
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
Founded
Employees
40
Employees40

AEZS Key Statistics

Market cap
13.02M
Market cap13.02M
Price-Earnings ratio
-0.44
Price-Earnings ratio-0.44
Dividend yield
Dividend yield
Average volume
1.35K
Average volume1.35K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$4.61
52 Week high$4.61
52 Week low
$1.96
52 Week low$1.96

Stock Snapshot

As of today, Aeterna Zentaris(AEZS) shares are valued at $4.10. The company's market cap stands at 13.02M, with a P/E ratio of -0.44.

During the trading day, Aeterna Zentaris(AEZS) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 1.35K.

The stock's 52-week range extends from a low of $1.96 to a high of $4.61.

The stock's 52-week range extends from a low of $1.96 to a high of $4.61.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.